abstract |
The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, nand methods of using the same. In certain embodiments, an antibody of the present disclosure nincludes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an n5 epitope present on KLB. n17911767_1 (GHMatters) P103043.AU.2 |